This work is licensed under a Creative Commons Attribution 4.0 International License.
| DRACP ID | Peptide Name | Sequence | Sequence Length | C terminal |
|---|---|---|---|---|
| DRACP01381 | Sequence 57 from Patent US 20110319336 | MEPVDPRLEPWKHPGSQPKTACTNCYCKKCCFHCQVCFITKALGISYGRKKRRQRRRAHQNSQTHQASLSKQPTSQPRGDPTGPKE | 86 | Not available |
| DRACP01382 | Sequence 5 from Patent US 20110319336 | MQLPLAT | 7 | Not available |
| DRACP01383 | Sequence 29 from Patent US 20110319336 | NYQWVPYQGRVPYPR | 15 | Not available |
| DRACP01384 | Sema3A(aa363-377) -kLytic | NYQWVPYQGRVPYPRGGGKLLLKLLKKLLKlLKKK | 35 | Free |
| DRACP01385 | Sequence 20 from Patent US 20110319336 | NYQWVPYQGRVPYPRGGGKLLLKLLKKLLKLLKKK | 35 | Not available |
| DRACP01386 | Sema3A(aa363-377) -nLytic | NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL | 32 | Free |
| DRACP01387 | Sequence 13 from Patent US 20110319336 | RLLRRLLRRLLRK | 13 | Not available |
| DRACP01388 | Sequence 12 from Patent US 20110319336 | RLLRRLLRRLLRRLLRRLLR | 20 | Not available |
| DRACP01389 | Sequence 58 from Patent US 20110319336 | RQIKIQFQNRRMKWKK | 16 | Not available |
| DRACP01390 | Sequence 25 from Patent US 20110319336 | RQIKIQFQNRRMKWKKKAYARIGNSYFK | 28 | Not available |
| DRACP01391 | Sequence 38 from Patent US 20110319336 | SNEW | 4 | Not available |
| DRACP01392 | Sequence 34 from Patent US 20110319336 | THRPPMWSPVWP | 12 | Not available |
| DRACP01393 | Tfr-lytic | THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK | 32 | Free |
| DRACP01394 | Sequence 32 from Patent US 20110319336 | VEPNCDIHVMWEWECFERL | 19 | Not available |
| DRACP01395 | Sequence 39 from Patent US 20110319336 | WDLAWMFRLPVG | 12 | Not available |
| DRACP01396 | Sequence 31 from Patent US 20110319336 | WHSDMEWWYLLG | 12 | CONH2 is existing at C-terminal |
| DRACP01397 | Sequence 16 from Patent US 20110319336 | WHSDMEWWYLLGGGGKLlLKlLkkLLKlLKKK | 32 | Free |
| DRACP01398 | Sequence 55 from Patent US 20110319336 | WTGWCLNPEESTWGFCTGSF | 20 | Not available |
| DRACP01399 | Sequence 30 from Patent US 20110319336 | YCDGFYACYMDV | 12 | Not available |
| DRACP01400 | Sequence 15 from Patent US 20110319336 | YCDGFYACYMDVGGGKLlLKlLkkLLKlLKKK | 32 | Free |
| DRACP01401 | Sequence 7 from Patent US 20110319336 | YHWYGYTPQNVI | 12 | Not available |
| DRACP01402 | Sequence 21 from Patent US 20110319336 | YHWYGYTPQNVIGGGGGRLLRRLLRRLLRK | 30 | Not available |
| DRACP01403 | EB-lytic | YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK | 32 | Free |
| DRACP01404 | Sequence 42 from Patent US 20110319336 | YHWYGYTPQNVIGGGLLkLLKklLKKLlKL | 30 | Free |
| DRACP01405 | Sequence 10 from Patent US 20110319336 | YKWYGYTPQNVI | 12 | Not available |
| DRACP01406 | Sequence 9 from Patent US 20110319336 | YRWYGYTPQNVI | 12 | Not available |
| DRACP01407 | EB(H2R)-lytic | YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK | 32 | Free |
| DRACP01408 | Sequence 6 from Patent US 20120302729 | CQDLFGRAPSKAVNPDEA | 18 | Not available |
| DRACP01409 | Sequence 9 from Patent US 20120302729 | DLFGR | 5 | Not available |
| DRACP01410 | Sequence 11 from Patent US 20120302729 | DLFGRAP | 7 | Not available |
This work is licensed under a Creative Commons Attribution 4.0 International License.